Briacell Therapeutics Corp (BCTX) — Cash Flow-to-Debt Ratio
Briacell Therapeutics Corp (BCTX) has a Cash Flow-to-Debt Ratio of -1.93x as of April 2026, meaning its operating cash flow of $-7.08 Million could theoretically repay -2% of its total liabilities ($3.66 Million) in one year. See Briacell Therapeutics Corp free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Briacell Therapeutics Corp Cash Flow-to-Debt Ratio (2006–2025)
Historical debt coverage capacity for Briacell Therapeutics Corp across 20 annual periods. For the full cash flow conversion analysis, see Briacell Therapeutics Corp cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for Briacell Therapeutics Corp (2006–2025)
Year-by-year debt coverage analysis for Briacell Therapeutics Corp. Check BCTX cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -6.59x | $-39.07 Million | $5.93 Million | ▼ -137.3% |
| 2024 | -2.78x | $-32.97 Million | $11.88 Million | ▼ -259.6% |
| 2023 | -0.77x | $-31.89 Million | $41.32 Million | ▼ -101.1% |
| 2022 | -0.38x | $-15.87 Million | $41.36 Million | ▼ -47.4% |
| 2021 | -0.26x | $-9.89 Million | $37.96 Million | ▲ +31.0% |
| 2020 | -0.38x | $-1.55 Million | $4.12 Million | ▲ +91.6% |
| 2019 | -4.52x | $-5.12 Million | $1.13 Million | ▼ -22.2% |
| 2018 | -3.70x | $-4.95 Million | $1.34 Million | ▼ -71.3% |
| 2017 | -2.16x | $-1.91 Million | $885.90K | ▲ +93.4% |
| 2016 | -32.48x | $-1.58 Million | $48.59K | ▼ -220.7% |
| 2015 | -10.13x | $-1.19 Million | $117.17K | ▲ +36.2% |
| 2014 | -15.87x | $-397.42K | $25.04K | ▼ -209.6% |
| 2013 | -5.13x | $-381.80K | $74.46K | ▼ -280.4% |
| 2012 | -1.35x | $-382.74K | $283.94K | ▼ -47.1% |
| 2011 | -0.92x | $-656.68K | $716.66K | ▲ +91.6% |
| 2010 | -10.93x | $-318.63K | $29.15K | ▼ -364.5% |
| 2009 | -2.35x | $-151.05K | $64.19K | ▲ +59.0% |
| 2008 | -5.73x | $-89.68K | $15.64K | ▲ +37.4% |
| 2007 | -9.16x | $-87.76K | $9.58K | ▼ -13544.3% |
| 2006 | 0.07x | $1.13K | $16.54K | — |